The Pulmonary Injury and Repair Center at the University of Alabama at Birmingham has produced a major return on investment in its six years of existence. The Center, begun in 2008 with an initial investment of $140,000 from the UAB School of Medicine, Department of Anesthesiology and Southern Research Institute, has since received nearly $10 million in research funding from government and industry sources.
Those funds have spurred scientific research, recruited new faculty and produced new knowledge in treating lung injury, especially from chemical agents such as chlorine, ammonia and bromine.
Chlorine, ammonia and bromine are commonly used in various industrial applications and are routinely shipped across the country. Exposure to these agents could come as a result of a deliberate terror attack or from an inadvertent leak from a transportation mishap.
“Inhalation of these gases can cause extreme, possibly fatal injury to the lungs,” said Sadis Matalon, Ph.D., distinguished professor and vice chair for research in the Department of Anesthesiology, and director of the center. “Our research is geared toward finding countermeasures that could be employed to minimize pulmonary injury in the event of a chlorine, ammonia or bromine release, whatever the cause may be.”
The UAB center is part of the federal government’s CounterACT Program. Funded by the National Institutes of Health, CounterACT is a translational research program aimed at the discovery and/or identification of better therapeutic medical countermeasures and technologies against chemical threat agents. CounterACT was launched following the terror attacks on Sept. 11, 2001, as awareness grew of potential threats from chemical agents.
UAB is one of the few research institutions in the nation involved in countermeasure research against chlorine and ammonia, and it is the only site looking for agents that would be effective against bromine, according to Matalon.
“We are investigating multiple strategies to respond to lung injury in the event of exposure to these agents,” Matalon said. “We have identified compounds that in preliminary studies have been shown to prevent death after chlorine exposure, for example. Compounds such as antioxidants and nitrites also have promise in reducing or reversing the toxic effects of these agents.”
Matalon says one of the center’s strengths is its reach across the breadth of UAB. Investigators involved in the major projects come from multiple disciplines and include Victor Darley-Usmar, Ph.D., and Jianhua Zhang, Ph.D., pathology; Tim Ness, M.D., anesthesiology; Chad Steele, Ph.D., and Veena Antony, M.D., pulmonary medicine; Rakesh Patel, Ph.D., molecular and cellular pathology; Mohammad Athar, dermatology; and Anupam Agarwal, M.D., nephrology. Other prominent investigators include Edward Postlethwait, Ph.D., Michelle Fanucchi, Ph.D., and Giuseppe Squadrito, Ph.D., in the School of Public Health; as well as James and Diana Noah, Ph.D.s, with Southern Research Institute.
Matalon and Darley-Usmar received a grant to test the role of mitochondrial injury in the initiation and propagation of chlorine injury to the lungs. Matalon is also collaborating with Sven Eric Jordt, Ph.D., of Yale University, to test the effectiveness of a new class of anti-inflammatory agents to decrease chlorine injury.
Patel was recently funded by the CounterACT Program to test the efficacy of nitrites to decrease mortality and lung injury in chlorine-exposed animals. Athar is funded by CounterACT to develop therapeutic interventions of lewisite-mediated injury to the skin, which could contribute to lung injury. Ness was also funded to investigate whether local anesthetics administered post-exposure reduce pain.
“This is a critical issue because people who experience pain have decreased ability to walk away from the epicenter of a chemical attack,” Matalon said.
The center also played a role in the recruitment of prominent new faculty to UAB, says Matalon, including Victor Thannickal, M.D., chair of the Division of Pulmonary, Allergy and Critical Care Medicine, and Jean-Francois Pittet, M.D., professor of anesthesiology.
“The Pulmonary Injury and Repair Center has enhanced collaborations among basic and clinical investigators at UAB and has driven translational research in lung injury and repair,” Matalon said. “It has also strengthened existing interactions among researchers from UAB and Southern Research Institute. These interactions continue to improve our ability to attract new faculty interested in pulmonary research at UAB and to compete for extramural awards.”
Fixing cystic fibrosis: In vitro studies show therapeutically robust correction of the most common CF gene mutationCystic fibrosis lung cells were restored to 50 percent of healthy function in work that provides the first evidence that novel therapeutic strategies for human patients can be identified based on yeast studies.posted today 146 viewsResearcher’s lifesaving raceways invention goes internationalUAB engineering professor Dean Sicking’s SAFER Barriers will be installed at the historic Le Mans Race Circuit.posted 6 days ago 1116 viewsS&P raises UAB bond ratings on very strong financial and enterprise profilesIdentifying a stable outlook and UAB’s very strong enterprise and financial profile, S&P Global Ratings has raised its rating on various series of general revenue bonds issued by The University of Alabama System Board of Trustees on behalf of UAB.posted 6 days ago 679 viewsHIV vaccine design should adapt as HIV virus mutatesResearchers from UAB, Emory and Microsoft demonstrate that HIV has evolved to be pre-adapted to the immune response, worsening clinical outcomes in newly infected patients.posted 9 days ago 2337 viewsMore than 10 risk factors identified in readmission of pediatric neurosurgery patientsBig data provides insight into patient readmission after pediatric neurosurgery.posted 8 days ago 1834 viewsRheumatoid arthritis: seeking an answer, cell by cellUAB researchers will use a $1.8 million grant to look at single cells for altered expression of the interferon gamma receptor gene.posted 13 days ago 1866 viewsA focus on homelessness as VA and UAB researchers mark National VA Research WeekVA Research support for UAB clinicians and scientists has been important for six decades.posted 14 days ago 1171 viewsRural children at risk for worse health outcomes, higher health care costsResearchers at UAB look to integrate health care within rural communities to improve care for children.posted 13 days ago 1807 views
After 30 years at UAB, VP Marchase announces plans to retireLongtime VP for Research and Economic Development Richard B. Marchase, Ph.D., plans to retire at the end of 2016. During his tenure, UAB annual research expenditures grew from $331 million to $510 million.posted 15 days ago 2181 viewsResearchers find potential breakthrough in binge-eating disorder treatmentA treatment used for depression, Parkinson’s disease and autism shows promise to alleviate obesity in binge-eating disorder patients.posted 16 days ago 3211 viewsUAB Hospital recognized for decreasing inappropriate use of antibioticsAntibiotic use in acute and long-term care facilities is a focus of UAB’s antibiotic stewardship program.posted 19 days ago 1945 viewsTen-year-old finds relief from rare eyelash growthDaniel Deligio, O.D., treats a rare disease and provides successful treatment plan for Sam Peppers.posted 20 days ago 1969 viewsParkinson’s disease pathogenesis is reduced in a rat model using a cell-signaling inhibitor drugResults show that JAK/STAT pathway inhibitors may be a new class of therapeutic treatments for patients with Parkinson’s disease. Acting by reducing inflammation, they prevent neurodegeneration in animal models and may be an important new approach to slow progression of the disease.posted 22 days ago 2327 viewsUAB driving simulator lab has national debut live on TODAYCutting-edge technology and research brings national attention to UAB.posted 26 days ago 3286 viewsStudy shows how different people respond to aspirin — an important cardioprotective drugUnderstanding how people respond to aspirin is key in terms of knowing who will benefit from it.posted 27 days ago 1421 viewsDepartment of Ophthalmology to host 2016 Clinical and Research SymposiumThe University of Alabama at Birmingham School of Medicine and Department of Ophthalmology will host the 2016 Annual Clinical and Research Symposium on May 13-14 at the Westin Birmingham.posted 27 days ago 716 viewsStudy to test ways to improve cognitive functioning of older adults with HIVUAB School of Nursing Professor David Vance, Ph.D., received a five-year, $2.86 million R01 grant to test ways of improving cognitive function in older adults with HIV.posted 29 days ago 1192 viewsFirst-of-its-kind driving simulator lab at UAB powered by donation from Honda Manufacturing of Alabama and ALDOTThe facility will enable new distracted-driving research, addressing a major public health issue that is a leading cause of highway and traffic-related injuries and death.posted a while back 3171 viewsUAB looking for healthy adults to participate in study on blood pressureThe UAB Division of Rheumatology and Immunology and the Division of Cardiovascular Disease look at effects of Allopurinol in healthy adults age 18-40.posted a while back 1278 viewsUAB observational study of Zika virus infection during pregnancy begins in BrazilUAB professor leads study in Brazil to help further understand the effects of Zika virus during pregnancy.posted a while back 2519 views